Mirum Pharmaceuticals (MIRM) Other Gross PP&E Adjustments (2018 - 2026)
Mirum Pharmaceuticals' quarterly Other Gross PP&E Adjustments came in at -$35.2 million in Q1 2026, down 62.84% year-on-year from -$94.8 million in Q1 2025, and down 35.31% quarter-over-quarter from -$26.0 million in Q4 2025.
Mirum Pharmaceuticals has reported Other Gross PP&E Adjustments for 9 years, with the latest figure at -$35.2 million in Q1 2026.
- For the quarter ending Q1 2026, Other Gross PP&E Adjustments fell 62.84% year-over-year to -$35.2 million; the trailing twelve-month figure through Mar 2026 stood at -$35.2 million (down 62.84% YoY), and the FY2025 full-year result was -$26.0 million, down 22.68% from the prior year.
- Other Gross PP&E Adjustments for Q1 2026 stood at -$35.2 million, down from -$26.0 million in the prior quarter.
- The five-year high for Other Gross PP&E Adjustments was -$5.3 million in Q2 2022, with the low at -$35.2 million in Q1 2026.
- Average Other Gross PP&E Adjustments over 5 years is -$15.6 million, with a median of -$10.9 million recorded in 2023.
- Year-over-year, Other Gross PP&E Adjustments slipped 1.33% in 2022 and tumbled 167.0% in 2024.
- Tracing MIRM's Other Gross PP&E Adjustments over 5 years: stood at -$6.8 million in 2022, then slumped by 35.6% to -$9.2 million in 2023, then slumped by 130.03% to -$21.2 million in 2024, then decreased by 22.68% to -$26.0 million in 2025, then tumbled by 35.31% to -$35.2 million in 2026.
- The last three Other Gross PP&E Adjustments figures came in at -$35.2 million (Q1 2026), -$26.0 million (Q4 2025), and -$21.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -189.30 Mn |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn | -35.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -35.23 Mn |
| Mar 31, 2026 | -35.23 Mn |
| Dec 31, 2025 | -26.03 Mn |
| Dec 31, 2025 | -26.03 Mn |
| Sep 30, 2025 | -21.39 Mn |
| Sep 30, 2025 | -21.39 Mn |
| Jun 30, 2025 | -22.97 Mn |
| Jun 30, 2025 | -22.97 Mn |
| Mar 31, 2025 | -21.63 Mn |
| Mar 31, 2025 | -21.63 Mn |
| Dec 31, 2024 | -21.22 Mn |
| Dec 31, 2024 | -21.22 Mn |
| Sep 30, 2024 | -20.99 Mn |
| Sep 30, 2024 | -20.99 Mn |
| Jun 30, 2024 | -21.89 Mn |
| Jun 30, 2024 | -21.89 Mn |
| Mar 31, 2024 | -10.00 Mn |
| Mar 31, 2024 | -10.00 Mn |
| Dec 31, 2023 | -9.23 Mn |
| Dec 31, 2023 | -9.23 Mn |
| Sep 30, 2023 | -10.93 Mn |
| Sep 30, 2023 | -10.93 Mn |
| Jun 30, 2023 | -8.20 Mn |
| Jun 30, 2023 | -8.20 Mn |
| Mar 31, 2023 | -9.26 Mn |
| Mar 31, 2023 | -9.26 Mn |
| Dec 31, 2022 | -6.80 Mn |
| Dec 31, 2022 | -6.80 Mn |
| Sep 30, 2022 | -7.08 Mn |
| Sep 30, 2022 | -7.08 Mn |
| Jun 30, 2022 | -5.33 Mn |
| Jun 30, 2022 | -5.33 Mn |
| Mar 31, 2022 | -6.46 Mn |
| Mar 31, 2022 | -6.46 Mn |
| Dec 31, 2021 | -4.03 Mn |
| Dec 31, 2021 | -4.03 Mn |
| Sep 30, 2021 | -6.13 Mn |
| Sep 30, 2021 | -6.13 Mn |
| Jun 30, 2021 | -5.26 Mn |
| Jun 30, 2021 | -5.26 Mn |
| Mar 31, 2021 | -4.68 Mn |
| Mar 31, 2021 | -4.68 Mn |
| Dec 31, 2020 | -4.11 Mn |
| Dec 31, 2020 | -4.11 Mn |
| Sep 30, 2020 | -3.36 Mn |
| Sep 30, 2020 | -3.36 Mn |
| Jun 30, 2020 | -3.03 Mn |
| Jun 30, 2020 | -3.03 Mn |
| Mar 31, 2020 | -3.09 Mn |
| Mar 31, 2020 | -3.09 Mn |
| Dec 31, 2019 | -3.35 Mn |
| Dec 31, 2019 | -3.35 Mn |
| Sep 30, 2019 | -2.04 Mn |
| Sep 30, 2019 | -2.04 Mn |
| Jun 30, 2019 | -1.89 Mn |
| Jun 30, 2019 | -1.89 Mn |
| Dec 31, 2018 | -70,000.00 |
| Dec 31, 2018 | -70,000.00 |